Financials
Financial year 2025
Minerva Pharma Consulting from Keerbergen, company number BE0798842609, closed financial year 2025 with a result of € 97,985 after tax. For that financial year Minerva Pharma Consulting recorded a gross margin of € 127,471 and equity of € 3,000. Compared with financial year 2024, the result moved from € 80,559 to € 97,985. Profitable, and profit is growing. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on February 2, 2026.
€ 3,000
▼ 98% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 97,985
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 246,386
▲ 60% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 254,528 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,926
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 2,223
▼ 16% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 50,567
▲ € 40,571 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 99,864 | € 105,487 | € 127,471 | ▲ 21% |
| Profit after taxes | € 77,643 | € 80,559 | € 97,985 | ▲ 22% |
| Equity | € 79,843 | € 159,543 | € 3,000 | ▼ 98% |
| Total debts | € 32,827 | € 13,247 | € 269,138 | ▲ € 255,891 |
| Cash | € 64,889 | € 154,048 | € 246,386 | ▲ 60% |
| Retained profit | € 76,843 | € 156,543 | € 0 | ▼ 100% |
| Dividend | € 800 | € 859 | € 254,528 | ▲ € 253,669 |
| Balance sheet total | € 112,671 | € 172,790 | € 272,138 | ▲ 57% |
Key figures of Minerva Pharma Consulting, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Minerva Pharma Consulting?
What happened at Minerva Pharma Consulting in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 97,985 (▲ 22% vs 2024). Source: NBB ↗
- New establishment in Keerbergen. KBO
- Start of the company according to the CBE. KBO
In short
From € 77,643 profit in 2023 to € 97,985 profit in 2025.
Paid € 68,956 in corporate taxes since 2023.
Best year ever: 2025, with € 97,985 profit.
Paid out € 256,187 in dividends to the owners in total.
A new publication or filing at Minerva Pharma Consulting? We notify you, reason included.
Follow Minerva Pharma ConsultingDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Minerva Pharma Consulting is Laurens Minerva.
Directors
According to the 2025 annual accounts
Laurens Minerva
Director
Establishments
Establishment units
Physical locations of this company
Viooltjesweg 19
3140 Keerbergen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0798.842.609
- VAT number
- BE 0798.842.609
- Registered office
- Viooltjesweg 19, 3140 Keerbergen
- Names & denominations
- Minerva Pharma Consulting
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 February 2023
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige vormen van onderwijs
Activiteiten van reclamebureaus
Overige zakelijke dienstverlening, neg
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
+1